Amlodipin/valsartan/hidroklorotiazid Genepharm 10 mg/160 mg/12,5 mg filmom obložene tablete
| Name | Amlodipin/valsartan/hidroklorotiazid Genepharm 10 mg/160 mg/12,5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-539208605 |
| Active Substance | amlodipinbesilat valsartan hidroklorotiazid |
| Composition | svaka filmom obložena tableta sadrži 10 mg amlodipina (u obliku amlodipinbesilata), 160 mg valsartana i 12,5 mg hidroklorotiazida |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Pharmadox Healthcare Limited, Paola, Malta Genepharm S.A., Pallini, Attiki, Grčka Pharmacare Premium Ltd., Birzebbugia, Malta |
| Marketing Authorisation Holder | Genepharm S.A., 18th km. Marathonos Avenue, Pallini, Attiki, Grčka |
| Marketing Authorisation Date | 09.06.2025 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/25-02/16 |
| Registration Number | 381-12-01/171-25-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09DX01 |
| Marketing status | nije stavljeno u promet |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
